Physician Office Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This 970-page report provides comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

This report will help diagnostic reagent and instrument suppliers develop more effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the physician office/group practice diagnostics market, including its dynamics,
  trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry,
  immunodiagnostic, microbiology, hematology and coagulation procedures, including:

- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers,
  both currently marketed and those in development, including their operating characteristics,
  features and selling prices.

Technology Review

- Emerging technologies and their applications for physician office/group practice
  diagnostic testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies
  and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales,
  product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially
  significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and the proprietary data files.

Europe Hepatitis Diagnostic Testing for 10 Markers, 2019-2023: Supplier Shares and Sales Segment Forecasts for Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK).  Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

USD 6500 View Report

Global Hepatitis Diagnostic Testing for 10 Markers, 2019-2023: Supplier Shares and Sales Segment Forecasts for Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition,

USD 8500 View Report

Europe Hepatitis Diagnostic Testing for 10 Markers, 2019-2023: Supplier Shares and Sales Segment Forecasts for Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK).  Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

USD 6500 View Report

Global Hepatitis Diagnostic Testing for 10 Markers, 2019-2023: Supplier Shares and Sales Segment Forecasts for Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition,

USD 8500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available